Liquid biopsy at the frontier in renal cell carcinoma: recent analysis of techniques and clinical application
M Li, L Li, J Zheng, Z Li, S Li, K Wang, X Chen - Molecular Cancer, 2023 - Springer
Renal cell carcinoma (RCC) is a major pathological type of kidney cancer and is one of the
most common malignancies worldwide. The unremarkable symptoms of early stages …
most common malignancies worldwide. The unremarkable symptoms of early stages …
Risks from deferring treatment for genitourinary cancers: a collaborative review to aid triage and management during the COVID-19 pandemic
Context The coronavirus disease 2019 (COVID-19) pandemic is leading to delays in the
treatment of many urologic cancers. Objective To provide a contemporary picture of the risks …
treatment of many urologic cancers. Objective To provide a contemporary picture of the risks …
Anti–PD-1 and anti–PD-L1 in head and neck cancer: a network meta-analysis
A Botticelli, A Cirillo, L Strigari, F Valentini… - Frontiers in …, 2021 - frontiersin.org
Objective The monoclonal antibodies anti-programmed death protein-1 (anti–PD-1)
nivolumab and pembrolizumab are the first immune checkpoint inhibitors (ICIs) approved for …
nivolumab and pembrolizumab are the first immune checkpoint inhibitors (ICIs) approved for …
RRM2 regulates sensitivity to sunitinib and PD‐1 blockade in renal cancer by stabilizing ANXA1 and activating the AKT pathway
Renal cell carcinoma (RCC) is a malignant tumor of the kidneys. Approximately 70% of RCC
cases are clear cell renal cell carcinoma with von Hippel–Lindau (VHL) gene mutation and …
cases are clear cell renal cell carcinoma with von Hippel–Lindau (VHL) gene mutation and …
[HTML][HTML] Downregulated METTL14 accumulates BPTF that reinforces super-enhancers and distal lung metastasis via glycolytic reprogramming in renal cell carcinoma
C Zhang, L Chen, Y Liu, J Huang, A Liu, Y Xu… - Theranostics, 2021 - ncbi.nlm.nih.gov
Background: Methyltransferase-like 14 (METTL14) participates in tumorigenesis in several
malignancies, but how METTL14 mediates the metastasis of renal cell carcinoma (RCC) has …
malignancies, but how METTL14 mediates the metastasis of renal cell carcinoma (RCC) has …
Tyrosine kinase inhibitors and immunotherapy combinations in renal cell carcinoma
The treatment landscape of metastatic renal cell carcinoma (mRCC) has been transformed
with the advent of antiangiogenics, notably tyrosine kinase inhibitors (TKIs) targeting …
with the advent of antiangiogenics, notably tyrosine kinase inhibitors (TKIs) targeting …
Renal cell carcinoma therapy: current and new drug candidates
Renal cell carcinoma (RCC) is the most common and lethal tumor of the urological system.
Curative treatment of localized RCC includes nephrectomy, radio-ablation, and active …
Curative treatment of localized RCC includes nephrectomy, radio-ablation, and active …
A living, interactive systematic review and network meta-analysis of first-line treatment of metastatic renal cell carcinoma
Context Identifying the most effective first-line treatment for metastatic renal cell carcinoma
(mRCC) is challenging as rapidly evolving data quickly outdate the existing body of …
(mRCC) is challenging as rapidly evolving data quickly outdate the existing body of …
Comparative safety of tyrosine kinase inhibitors in the treatment of metastatic renal cell carcinoma: a systematic review and network meta-analysis
K Krawczyk, K Śladowska, P Holko… - Frontiers in …, 2023 - frontiersin.org
Objective: This study aimed to compare the safety profile of tyrosine kinase inhibitors (TKIs)
approved for use as monotherapy or combination therapy for the first-line treatment of adult …
approved for use as monotherapy or combination therapy for the first-line treatment of adult …
Epstein–Barr Virus (EBV) Epithelial Associated Malignancies: Exploring Pathologies and Current Treatments
O Shechter, DG Sausen, ES Gallo, H Dahari… - International Journal of …, 2022 - mdpi.com
Epstein–Barr virus (EBV) is one of eight known herpesviruses with the potential to infect
humans. Globally, it is estimated that between 90–95% of the population has been infected …
humans. Globally, it is estimated that between 90–95% of the population has been infected …